Predicting progression in primary progressive multiple sclerosis: A 10-year multicenter study

Annals of Neurology

Volumn 63, Issue 6, 2008, Pages 790-793

  Khaleeli, Zhaleh ^a   Ciccatelli, Oka ^a   Manfredonia, Francesco ^a   Barkhof, Frederik ^b   Brochet, Bruno ^c   Cercignani, Mata ^a   Dousset, Vincent ^d   Filippi, Massimo ^e   Montalban, Xavier ^f   Polman, Chris ^b   Rovaris, Marco ^e   Rovira, Alex ^f   Sastre Garriga, Jaume ^a,f   Vellinga, Machteld ^b   Miller, David ^a   Thompson, Alan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HÔPITAL PELLEGRIN   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DISEASE COURSE; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; FEMALE; FRANCE; HUMAN; HUMAN TISSUE; ITALY; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; NETHERLANDS; PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SEX DIFFERENCE; SPAIN; UNITED KINGDOM; WALKING SPEED;

ADULT; AGED; ATROPHY; BRAIN; DISABILITY EVALUATION; DISEASE PROGRESSION; FEMALE; GAIT DISORDERS, NEUROLOGIC; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; SPINAL CORD; TIME FACTORS;

EID: 46749140311     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.21375     Document Type: Article

References (20)

1. Ingle GT, Sastre-Garriga J, Miller DH, et al. Is inflammation important in early PPMS? A longitudinal MRI study. J Neurol Neurosurg Psychiatry 2005;76:1255-1258.
2. Tremlett H, Paty D, Devonshire V. The natural history of primary progressive MS in British Columbia, Canada. Neurology 2005;65:1919-1923.
3. Confavreux C, Vukusic S, Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 2003;126:770-782.
4. Cottrell DA, Kremenchutzky M, Rice GP, et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 1999;122(pt 4):625-639.
5. Wolinsky JS, Narayana PA, O'Connor P, et al. Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial. Ann Neurol 2007;61:14-24.
6. Thompson A. Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis. Mult Scler 2004;10(suppl 1):S2-S7.
7. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007;6:903-912.
8. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
9. Cutter GR, Baier ML, Rudick RA, et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain 1999;122(pt 5):871-882.
10. Stevenson VL, Miller DH, Rovaris M, et al. Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 1999;52:839-845.
11. Stevenson VL, Miller DH, Leary SM, et al. One year follow up study of primary and transitional progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;68:713-718.
12. Ingle GT, Stevenson VL, Miller DH, et al. Two-year follow-up study of primary and transitional progressive multiple sclerosis. Mult Scler 2002;8:108-114.
13. Sastre-Garriga J, Ingle GT, Rovaris M, et al. Long-term clinical outcome of primary progressive MS: predictive value of clinical and MRI data. Neurology 2005;65:633-635.
14. Lechner-Scott J, Kappos L, Hofman M, et al. Can the Expanded Disability Status Scale be assessed by telephone? Mult Scler 2003;9:154-159.
15. Losseff NA, Webb SL, O'Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996;119(pt 3):701-708.
16. Losseff NA, Wang L, Lai HM, et al. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996;119(pt 6):2009-2019.
17. Miller DH, Leary SM. Primary-progressive multiple sclerosis. Lancet Neurol 2007;6:903-912.
18. Dutta R, Trapp BD. Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology 2007;68:S22-S31.
19. Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999;12:295-302.
20. Miller DH, Barkhof F, Frank JA, et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676-1695.